Recs

2

Gap Launches Growth Initiatives

In the past few years, Motley Fool Stock Advisor selection Gap (NYSE: GPS  ) has done a phenomenal job of improving its overall financial condition. Its balance sheet is proof enough of that. Growth, on the other hand, has been tough to come by.

The company is looking at several ways to restore growth to its brands, but the two that have me the most curious are the launch of its Forth & Towne stores and the debut of Banana Republic in Tokyo and Yokohama, Japan.

The Banana Republic openings in Japan are all in high-profile shopping areas, with plenty of other attractions to draw in the foot traffic. While the rents are likely to be quite high and the area is filled with competition, I think it's an experiment worth the effort. The Banana Republic stores should be able to piggyback on some of the existing infrastructure that supports the Gap stores in Japan.

Based on the information the company has provided, the Forth & Towne effort seems a bit more risky to me. First, this area is loaded with competition from the likes of Chico's FAS (NYSE: CHS  ) , Ann Taylor (NYSE: ANN  ) , and Federated (NYSE: FD  ) . The pictures of the stores on the Gap website do make me think that the company put a lot of thought into the customer experience, but I question the company's strategy of including the Gap Edition brand as one of Forth & Towne's offerings. I think the association with a lower-priced and more basic set of stores may put customers off. After all, if customers can get similar items at the Gap for a lower price, why go to Forth & Towne? Conversely, if Forth & Towne strips sales away from the Gap, it's tough to see what is gained.

The Forth & Towne openings and Japanese Banana Republic openings are important to watch, because they may indicate the entire company's potential future growth. However, with a total of nine stores announced between the two, it will be quite some time before either expansion has a material effect on Gap's numbers. That's not necessarily a bad thing. It allows the company time to see what is working and change course before getting in over its head. In the meantime, investors still have that solid balance sheet -- and a stock that isn't priced anywhere near perfection -- to fall back on.

For related Foolishness see:

Gap is a Motley Fool Stock Advisor pick. For more stylish companies from Tom & David Gardner's wardrobe of outstanding stocks, try a free 30-day subscription on for size.

Nathan Parmelee beneficially owns shares in Gap but has no financial interest in any of the other companies mentioned. The Motley Fool has an ironclad disclosure policy.


Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

DocumentId: 495549, ~/Articles/ArticleHandler.aspx, 5/23/2012 11:21:08 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 12,359.62 -143.19 -1.15%
S&P 500 1,302.54 -14.09 -1.07%
NASD 2,810.48 -28.60 -1.01%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

5/23/2012 11:05 AM
GPS $26.27 Down -0.22 -0.83%
Gap CAPS Rating: **
CHS $14.91 Down -0.16 -1.06%
Chico's FAS, Inc. CAPS Rating: ***
ANN $27.20 Up +0.54 +2.03%
ANN Inc. CAPS Rating: **

Advertisement